3FDN | Transferase | date | Nov 26, 2008 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure-Based Drug Design Of Novel Aurora Kinase A Inhibit Structure Basis For Potency And Specificity | ||||||||||||||
authors | J.S.Leou, J.S.Wu, M.S.Coumar, P.Shukla, H.P.Hsieh, S.Y.Wu | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Serinethreonine-Protein Kinase 6 Chain: A Fragment: Catalytic Domain Synonym: Aurora Kinase A, Aurora-A, Serinethreonine Kinase Auroraipl1-Related Kinase 1, Aurora-Related Kinase 1, Hark Tumor-Amplified Kinase; Ec: 2.7.11.1 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 Expression_system_strain: Bl21(De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet28a | ||||||||||||||
symmetry | Space Group: P 61 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 Å | ||||||||||||
ligand | MMH | enzyme | Transferase E.C.2.7.11.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity., Coumar MS, Leou JS, Shukla P, Wu JS, Dixit AK, Lin WH, Chang CY, Lien TW, Tan UK, Chen CH, Hsu JT, Chao YS, Wu SY, Hsieh HP, J Med Chem. 2009 Feb 26;52(4):1050-62. PMID:19140666 |
Data retrieval |
View 3FDN in 3D |
Visual 3D analysis of 3FDN |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3FDN |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |